Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics

Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics

Abstract Background Immune checkpoint inhibitors (ICIs) have emerged as one of the most promising first-line therapeutics in the management of non-small cell lung cancer (NSCLC). However, only a subset of these patients responds to ICIs, highlighting the clinical need to develop better predictive an...

Full description

Bibliographic Details
Main Authors: Sevinj Yolchuyeva, Leyla Ebrahimpour, Marion Tonneau, Fabien Lamaze, Michele Orain, François Coulombe, Julie Malo, Wiam Belkaid, Bertrand Routy, Philippe Joubert, Venkata SK. Manem
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Journal of Translational Medicine
Online Access:https://doi.org/10.1186/s12967-024-04854-z

Internet

https://doi.org/10.1186/s12967-024-04854-z

Similar Items